Lucinactant (trade name Surfaxin) is a liquid medication used to treat Infant Respiratory Distress Syndrome in infants. A synthetic human lung surfactant consisting of peptide KL4, dipalmitoylphosphatidylcholine, palmitoyloleoylphosphatidylglycerol, and palmitic acid. Sequence: KLLLLKLLLLKLLLLKLLLLK
Products > Drug Discovery > APIs > Generic APIs | Products > Drug Discovery > Inhibitor
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.
日本语
한국어
Français
Deutsch
España
Türkiye